Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scott

Showing results (221-230 of 355) with videos related to

Pageof 36
Sort By:
Blood|April 13, 2012
TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphomaDavid W Scott, Karen L Mungall, Susana Ben-Neriah, et al.
Blood|February 3, 2016
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCLKerry J Savage, Graham W Slack, Anja Mottok, et al.
Cell Reports|November 10, 2015
Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II ExpressionAnja Mottok, Bruce Woolcock, Fong Chun Chan, et al.
British Journal of Haematology|June 9, 2020
Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphomaLourdes Calvente, Rosemarie Tremblay-LeMay, Wei Xu, et al.
ACS Biomaterials Science & Engineering|January 19, 2021
3D Tissue-Engineered Tumor Model for Ewing's Sarcoma That Incorporates Bone-like ECM and MineralizationEric R Molina, Letitia K Chim, Maria C Salazar, et al.
Leukemia & Lymphoma|April 4, 2019
Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphomaJorne L Biccler, Kerry J Savage, Peter D N Brown, et al.
The Journal of Experimental Medicine|November 25, 2020
Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphomaRaud Razzaghi, Shreya Agarwal, Nikita Kotlov, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Primary Central Nervous System Lymphoma Tumor Biopsies Show Heterogeneity in Gene Expression Profiles, Genetic Subtypes, and in vitro Drug Sensitivity to Kinase InhibitorsYuan Xiao Zhu, Jasper Ch Wong, Talal Hilal, et al.
Blood Advances|August 18, 2023
Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCLJohn R Davies, Laura K Hilton, Aixiang Jiang, et al.
Clinical Chemistry|January 4, 2024
Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation SequencingJennifer M Grants, Christina May, Josh Bridgers, et al.
Pageof 36

Showing results (221-230 of 355) with videos related to

Sort By:
Pageof 36
Blood|April 13, 2012
TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphomaDavid W Scott, Karen L Mungall, Susana Ben-Neriah, et al.
Blood|February 3, 2016
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCLKerry J Savage, Graham W Slack, Anja Mottok, et al.
Cell Reports|November 10, 2015
Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II ExpressionAnja Mottok, Bruce Woolcock, Fong Chun Chan, et al.
British Journal of Haematology|June 9, 2020
Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphomaLourdes Calvente, Rosemarie Tremblay-LeMay, Wei Xu, et al.
ACS Biomaterials Science & Engineering|January 19, 2021
3D Tissue-Engineered Tumor Model for Ewing's Sarcoma That Incorporates Bone-like ECM and MineralizationEric R Molina, Letitia K Chim, Maria C Salazar, et al.
Leukemia & Lymphoma|April 4, 2019
Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphomaJorne L Biccler, Kerry J Savage, Peter D N Brown, et al.
The Journal of Experimental Medicine|November 25, 2020
Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphomaRaud Razzaghi, Shreya Agarwal, Nikita Kotlov, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Primary Central Nervous System Lymphoma Tumor Biopsies Show Heterogeneity in Gene Expression Profiles, Genetic Subtypes, and in vitro Drug Sensitivity to Kinase InhibitorsYuan Xiao Zhu, Jasper Ch Wong, Talal Hilal, et al.
Blood Advances|August 18, 2023
Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCLJohn R Davies, Laura K Hilton, Aixiang Jiang, et al.
Clinical Chemistry|January 4, 2024
Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation SequencingJennifer M Grants, Christina May, Josh Bridgers, et al.
Pageof 36